ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 950,17
0,11%
Dow Jones
44 544,66
-0,75%
DAX
21 732,05
0,01%
Brent Oil
76,385
0,00%
Bitcoin
99 585,29
-1,08%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. NovaBay Pharmaceuticals Inc New (NBY)

  7. NovaBay Pharmaceuticals Inc New (NBY) Actualités

NBY

NovaBay Pharmaceuticals (NBY)

NovaBay Pharmaceuticals Inc New
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:NBY
DateHeureSourceTitreSymboleSociété
23/01/202514h13Edgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
23/01/202514h12Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
23/01/202514h00Business WireNovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution ProposalAMEX:NBYNovaBay Pharmaceuticals Inc New
11/01/202500h06Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:NBYNovaBay Pharmaceuticals Inc New
19/12/202412h50Business WireNovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of StockholdersAMEX:NBYNovaBay Pharmaceuticals Inc New
09/12/202412h50Business WireNovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special MeetingAMEX:NBYNovaBay Pharmaceuticals Inc New
22/11/202422h05Business WireNovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024AMEX:NBYNovaBay Pharmaceuticals Inc New
15/11/202414h00Business WireProminent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova BrandAMEX:NBYNovaBay Pharmaceuticals Inc New
08/11/202423h31Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]AMEX:NBYNovaBay Pharmaceuticals Inc New
07/11/202422h13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:NBYNovaBay Pharmaceuticals Inc New
07/11/202422h05Business WireNovaBay Pharmaceuticals Reports Third Quarter 2024 Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
06/11/202422h05Business WireNovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase PriceAMEX:NBYNovaBay Pharmaceuticals Inc New
29/10/202413h00Business WireNovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLCAMEX:NBYNovaBay Pharmaceuticals Inc New
16/10/202422h19Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionAMEX:NBYNovaBay Pharmaceuticals Inc New
25/09/202423h17Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionAMEX:NBYNovaBay Pharmaceuticals Inc New
23/09/202415h27PR Newswire (US)Kuehn Law Encourages COFS, ARC, RFL, and NBY Investors to Contact Law FirmAMEX:NBYNovaBay Pharmaceuticals Inc New
20/09/202414h30PR Newswire (US)Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay PharmaceuticalsAMEX:NBYNovaBay Pharmaceuticals Inc New
20/09/202414h00Business WireNovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova AssetsAMEX:NBYNovaBay Pharmaceuticals Inc New
13/08/202422h05Business WireNovaBay Pharmaceuticals Reports Second Quarter 2024 Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
01/08/202412h50Business WireNovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024AMEX:NBYNovaBay Pharmaceuticals Inc New
30/07/202412h50Business WireNovaBay Pharmaceuticals Reports Record Amazon Prime Day SalesAMEX:NBYNovaBay Pharmaceuticals Inc New
29/07/202422h05Business WireNovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment OptionAMEX:NBYNovaBay Pharmaceuticals Inc New
26/07/202423h19Edgar (US Regulatory)Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]AMEX:NBYNovaBay Pharmaceuticals Inc New
26/07/202414h30Business WireNovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public OfferingAMEX:NBYNovaBay Pharmaceuticals Inc New
26/07/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:NBYNovaBay Pharmaceuticals Inc New
16/07/202412h50Business WireNovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime DayAMEX:NBYNovaBay Pharmaceuticals Inc New
11/07/202414h50Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:NBYNovaBay Pharmaceuticals Inc New
11/07/202412h50Business WireNovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 MillionAMEX:NBYNovaBay Pharmaceuticals Inc New
10/07/202415h30Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]AMEX:NBYNovaBay Pharmaceuticals Inc New
28/06/202412h50Business WireNovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product PromotionsAMEX:NBYNovaBay Pharmaceuticals Inc New
 Showing the most relevant articles for your search:AMEX:NBY

Dernières Valeurs Consultées

NYSE
MCD
McDonalds
EU
AF
Air FranceKLM
EU
BNP
BNP Paribas
COIN
DOGEUSD
Dogecoin
COIN
SOLUSD
Solana
EU
ML
Michelin
EU
ORA
Orange
EU
SGO
Cie de SaintGobain
NYSE
NKE
Nike
NYSE
MRK
Merck
EU
BEL20
Bel 20
EU
RNO
Renault
EU
MC
Lvmh Moet Hennessy Louis...
NASDAQ
MSFT
Microsoft
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces